Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients With Obesity and Mild Kidney Failure
- PMID: 32012661
- PMCID: PMC7071259
- DOI: 10.3390/nu12020333
Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients With Obesity and Mild Kidney Failure
Abstract
Very low-calorie ketogenic diets (VLCKD) are an effective and increasingly used tool for weight loss. Traditionally considered high protein, ketogenic diets are often looked at with concern by clinicians due to the potential harm they pose to kidney function. We herein evaluated the efficacy and safety of a VLCKD in patients with obesity and mild kidney failure. A prospective observational real-life study was conducted on ninety-two patients following a VLCKD for approximately 3 months. Thirty-eight had mild kidney failure and fifty-four had no renal condition and were therefore designated as control. Anthropometric parameters, bioelectrical impedance and biochemistry data were collected before and at the end of the dietary intervention. The average weight loss was nearly 20% of initial weight, with a significant reduction in fat mass. We report an improvement of metabolic parameters and no clinically relevant variation regarding liver and kidney function. Upon stratification based on kidney function, no differences in the efficacy and safety outcomes were found. Interestingly, 27.7% of patients with mild renal failure reported normalization of glomerular filtrate after dietary intervention. We conclude that, when conducted under the supervision of healthcare professionals, a VLCKD is an effective and safe treatment for weight loss in patients with obesity, including those affected by mild kidney failure.
Keywords: VLCD; VLCKD; chronic kidney disease; high protein diet; kidney function; low carbohydrate diet; renal function; safety; very low energy diet; very low-calorie diet.
Conflict of interest statement
All other authors declare no conflict of interest and have approved the final manuscript.
References
-
- World Health Organization Obesity and Overweight Fact Sheet. [(accessed on 1 November 2019)]; Available online: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Watanabe M., Gangitano E., Francomano D., Addessi E., Toscano R., Costantini D., Tuccinardi D., Mariani S., Basciani S., Spera G., et al. Mangosteen Extract Shows a Potent Insulin Sensitizing Effect in Obese Female Patients: A Prospective Randomized Controlled Pilot Study. Nutrients. 2018;10:586. doi: 10.3390/nu10050586. - DOI - PMC - PubMed
-
- Saper R.B., Eisenberg D.M., Phillips R.S. Common dietary supplements for weight loss. Am. Fam. Physician. 2004;70:1731–1738. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
